SCHEMBL14047581

SCHEMBL14047581

CC1N=C(N2CCN(c3ccccc3)C2=O)SC1C(=O)NCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ METAP2 P50579 1/20 0.42
▸ CACNA1G O43497 1/20 0.41
▸ CACNA1H O95180 1/20 0.41
▸ CACNA1I Q9P0X4 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SCD O00767 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ FKBP1A P62942 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14047539 0.88 SCD (0.53) ALDH1A1KMT2APOLBCACNA1GCACNA1H
SCHEMBL14047595 0.84 SCD (0.56) ALDH1A1CACNA1GCACNA1HCACNA1ISCD
SCHEMBL14047531 0.84 SCD (0.41) ALDH1A1KMT2APOLBCACNA1GCACNA1H
SCHEMBL14047625 0.83 SCD (0.57) ALDH1A1MEN1KMT2ACACNA1GCACNA1H
SCHEMBL14047400 0.83 SCD (0.57) ALDH1A1MEN1KMT2ACACNA1GCACNA1H
SCHEMBL14047407 0.82 SCD (0.44) ALDH1A1SCD
SCHEMBL14047582 0.80 ALDH1A1 (0.41) ALDH1A1KMT2APOLBSCDCYP3A4
SCHEMBL14047603 0.79 SCD (0.57) ALDH1A1MEN1KMT2ACACNA1GCACNA1H
SCHEMBL14047421 0.73 SCD (0.59) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL14047553 0.72 SCD (0.47) ALDH1A1MEN1KMT2APOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 — — WO disclosed
Send feedback